{"id":"W4394200467","doi":"10.6084/m9.figshare.23820684","title":"Supplementary Material for: An Open-label, Uncontrolled, Single-arm Clinical trial of Tofacitinib, an oral JAK1 and JAK3 kinase inhibitor, in Chinese patients with keloid","year":2023,"lang":"en","type":"dataset","venue":"Figshare","topic":"Systemic Sclerosis and Related Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tofacitinib; Medicine; Keloid; Open label; Janus kinase inhibitor; Internal medicine; Pharmacology; Kinase; Dermatology; Clinical trial; Chemistry; Rheumatoid arthritis","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001352839,0.001113648,0.001922663,0.0005487273,0.0006835604,0.0009684967,0.001190619,0.00168775,0.6210915],"category_scores_gemma":[0.00514867,0.0005233538,0.001036911,0.0007558135,0.0002090965,0.0008955704,0.0005379454,0.001309119,0.06562337],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000763085,"about_ca_system_score_gemma":0.001769779,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009714886,"about_ca_topic_score_gemma":0.002859316,"domain_scores_codex":[0.9995184,0.0001947829,0.000081742,0.00007881792,0.0000652041,0.00006108114],"domain_scores_gemma":[0.9974482,0.001362806,0.0003102962,0.0001767583,0.0003282142,0.0003737273],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.1061574,0.003898241,0.00163461,0.008128352,0.0009455721,0.0008138272,0.00004832175,0.0007202972,0.003475211,0.001910183,0.7352072,0.1370607],"study_design_scores_gemma":[0.5150383,0.03340259,0.022547,0.00436458,0.002089322,0.003128791,0.0001470507,0.003960938,0.004499678,0.007901007,0.4027373,0.0001834131],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.02410978,0.00580917,0.007660773,0.01021977,0.005751775,0.02341395,0.8638881,0.002364364,0.05678223],"genre_scores_gemma":[0.1632395,0.008608609,0.03596454,0.02052161,0.003738093,0.08992521,0.5145291,0.0009572429,0.162516],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.6210915,"threshold_uncertainty_score":0.5404669,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1189733422950536,"score_gpt":0.3794805278556044,"score_spread":0.2605071855605509,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}